CN101208431A - 用于肿瘤诊断和治疗的组合物和方法 - Google Patents

用于肿瘤诊断和治疗的组合物和方法 Download PDF

Info

Publication number
CN101208431A
CN101208431A CNA2006800198001A CN200680019800A CN101208431A CN 101208431 A CN101208431 A CN 101208431A CN A2006800198001 A CNA2006800198001 A CN A2006800198001A CN 200680019800 A CN200680019800 A CN 200680019800A CN 101208431 A CN101208431 A CN 101208431A
Authority
CN
China
Prior art keywords
antibody
tat
cell
polypeptide
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800198001A
Other languages
English (en)
Chinese (zh)
Inventor
帕特里克·多德
格雷奇恩·弗朗兹
保罗·波拉基斯
维多利亚·史密斯
苏珊·斯潘塞
吴棣
张泽民
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/102,501 external-priority patent/US20050272120A1/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of CN101208431A publication Critical patent/CN101208431A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNA2006800198001A 2005-04-08 2006-04-05 用于肿瘤诊断和治疗的组合物和方法 Pending CN101208431A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/102,501 US20050272120A1 (en) 2001-06-20 2005-04-08 Compositions and methods for the diagnosis and treatment of tumor
US11/102,501 2005-04-08

Publications (1)

Publication Number Publication Date
CN101208431A true CN101208431A (zh) 2008-06-25

Family

ID=38667206

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006800198001A Pending CN101208431A (zh) 2005-04-08 2006-04-05 用于肿瘤诊断和治疗的组合物和方法

Country Status (14)

Country Link
EP (1) EP1871886A2 (fr)
JP (1) JP2008535498A (fr)
KR (1) KR20080003405A (fr)
CN (1) CN101208431A (fr)
AU (1) AU2006235436A1 (fr)
BR (1) BRPI0609729A2 (fr)
CA (1) CA2604377A1 (fr)
CR (1) CR9486A (fr)
IL (1) IL185900A0 (fr)
MA (1) MA29587B1 (fr)
MX (1) MX2007012216A (fr)
NO (1) NO20075698L (fr)
RU (1) RU2007141407A (fr)
ZA (1) ZA200707967B (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102741294A (zh) * 2009-11-30 2012-10-17 霍夫曼-拉罗奇有限公司 治疗和诊断表达slc34a2(tat211=seqid2)的肿瘤的抗体
CN104284677A (zh) * 2012-05-14 2015-01-14 霍夫曼-拉罗奇有限公司 用于肿瘤诊断和治疗的组合物和方法
CN113939313A (zh) * 2019-06-06 2022-01-14 电化株式会社 以肽核酸为基础的佐剂
US12016920B2 (en) 2019-06-06 2024-06-25 Denka Company Limited Adjuvant based on peptide nucleic acid

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102741294A (zh) * 2009-11-30 2012-10-17 霍夫曼-拉罗奇有限公司 治疗和诊断表达slc34a2(tat211=seqid2)的肿瘤的抗体
CN103724432A (zh) * 2009-11-30 2014-04-16 霍夫曼-拉罗奇有限公司 治疗和诊断表达slc34a2(tat211=seqid 2)的肿瘤的抗体
CN103755809A (zh) * 2009-11-30 2014-04-30 霍夫曼-拉罗奇有限公司 治疗和诊断表达slc34a2(tat211 = seqid 2)的肿瘤的抗体
CN103755809B (zh) * 2009-11-30 2016-06-01 霍夫曼-拉罗奇有限公司 治疗和诊断表达slc34a2(tat211=seqid2)的肿瘤的抗体
CN103724432B (zh) * 2009-11-30 2016-06-08 霍夫曼-拉罗奇有限公司 治疗和诊断表达slc34a2(tat211=seqid2)的肿瘤的抗体
CN104284677A (zh) * 2012-05-14 2015-01-14 霍夫曼-拉罗奇有限公司 用于肿瘤诊断和治疗的组合物和方法
CN113939313A (zh) * 2019-06-06 2022-01-14 电化株式会社 以肽核酸为基础的佐剂
US12016920B2 (en) 2019-06-06 2024-06-25 Denka Company Limited Adjuvant based on peptide nucleic acid

Also Published As

Publication number Publication date
MA29587B1 (fr) 2008-07-01
IL185900A0 (en) 2008-01-06
AU2006235436A2 (en) 2006-10-19
NO20075698L (no) 2008-01-07
CR9486A (es) 2008-02-20
AU2006235436A1 (en) 2006-10-19
MX2007012216A (es) 2007-12-06
KR20080003405A (ko) 2008-01-07
EP1871886A2 (fr) 2008-01-02
JP2008535498A (ja) 2008-09-04
ZA200707967B (en) 2008-11-26
RU2007141407A (ru) 2009-05-20
BRPI0609729A2 (pt) 2010-04-20
CA2604377A1 (fr) 2006-10-19

Similar Documents

Publication Publication Date Title
CN101948541B (zh) 用于肿瘤诊断和治疗的组合物和方法
CN102985113B (zh) 用于肿瘤诊断和治疗的组合物和方法
US8398982B2 (en) Compositions and methods for the diagnosis and treatment of tumor
CN101263159A (zh) 用于肿瘤诊断和治疗的组合物和方法
US20070212735A1 (en) Compositions and Methods for the Diagnosis and Treatment of Tumor
KR20030029847A (ko) 종양의 진단 및 치료를 위한 조성물 및 방법
CN101336300A (zh) 神经胶质瘤的诊断、预后和治疗方法
CN102741294A (zh) 治疗和诊断表达slc34a2(tat211=seqid2)的肿瘤的抗体
CN104284677A (zh) 用于肿瘤诊断和治疗的组合物和方法
US20090054631A1 (en) Compositions and methods for treatment of non-hodgkin's lymphoma
US20090142259A1 (en) Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors
CN107090045A (zh) 用于肿瘤诊断和治疗的组合物和方法
CN101208431A (zh) 用于肿瘤诊断和治疗的组合物和方法
US20080193446A1 (en) Compositions and Methods for the Diagnosis and Treatment of Tumor
CN101595130B (zh) 用于肿瘤诊断和治疗的组合物和方法
CN101790539A (zh) 细胞应激应答的缓解

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20080625